| 走廊 | HS2 | 品类 | 累计额 | 出口 | 进口 | 增速 | |
| Saudi Arabia → Germany | 33 33 - Essenti | 医药·医疗 | 85.5 万 | 85.5 万 | 0 | +0.0% | 详情 |
| Pakistan → Philippines | 33 33 - Essenti | 医药·医疗 | 85.5 万 | 85.5 万 | 0 | +0.0% | 详情 |
| Nepal → Ireland | 33 33 - Essenti | 医药·医疗 | 85.3 万 | 85.3 万 | 0 | +0.0% | 详情 |
| Malaysia → Angola | 33 33 - Essenti | 医药·医疗 | 85.2 万 | 85.2 万 | 0 | +0.0% | 详情 |
| Kenya → Netherlands | 33 33 - Essenti | 医药·医疗 | 84.4 万 | 84.4 万 | 0 | +0.0% | 详情 |
| Indonesia → Poland | 33 33 - Essenti | 医药·医疗 | 84.4 万 | 84.4 万 | 0 | +0.0% | 详情 |
| Spain → Benin | 33 33 - Essenti | 医药·医疗 | 84.3 万 | 84.3 万 | 0 | +0.0% | 详情 |
| Azerbaijan → Georgia | 33 33 - Essenti | 医药·医疗 | 84.3 万 | 84.3 万 | 0 | +0.0% | 详情 |
| Nigeria → Dem. Rep. of the Congo | 33 33 - Essenti | 医药·医疗 | 84.2 万 | 84.2 万 | 0 | +0.0% | 详情 |
| Malaysia → Lebanon | 33 33 - Essenti | 医药·医疗 | 83.9 万 | 83.9 万 | 0 | +0.0% | 详情 |
| Netherlands → New Caledonia | 33 33 - Essenti | 医药·医疗 | 83.7 万 | 83.7 万 | 0 | +0.0% | 详情 |
| Sri Lanka → Philippines | 33 33 - Essenti | 医药·医疗 | 83.5 万 | 83.5 万 | 0 | +0.0% | 详情 |
| Cambodia → China, Hong Kong SAR | 33 33 - Essenti | 医药·医疗 | 83.4 万 | 83.4 万 | 0 | +0.0% | 详情 |
| Saudi Arabia → Canada | 33 33 - Essenti | 医药·医疗 | 83.2 万 | 83.2 万 | 0 | +0.0% | 详情 |
| Greece → Pakistan | 33 33 - Essenti | 医药·医疗 | 83.2 万 | 83.2 万 | 0 | +0.0% | 详情 |
| Iran → United Kingdom | 33 33 - Essenti | 医药·医疗 | 83.2 万 | 83.2 万 | 0 | +0.0% | 详情 |
| Pakistan → Spain | 33 33 - Essenti | 医药·医疗 | 83.0 万 | 83.0 万 | 0 | +0.0% | 详情 |
| Saudi Arabia → Myanmar | 33 33 - Essenti | 医药·医疗 | 82.6 万 | 82.6 万 | 0 | +0.0% | 详情 |
| Netherlands → Central African Rep. | 33 33 - Essenti | 医药·医疗 | 82.6 万 | 82.6 万 | 0 | +0.0% | 详情 |
| Spain → Burundi | 33 33 - Essenti | 医药·医疗 | 82.3 万 | 82.3 万 | 0 | +0.0% | 详情 |